How much funding has XtalPi raised?

XtalPi has raised $785.1M in total funding, most recently a series d round.

Who are XtalPi's investors?

XtalPi's investors include Tencent, SoftBank, PICC Capital Investment, Morningside Group, Sequoia China, Renren.

Where is XtalPi headquartered?

XtalPi is headquartered in Beijing, China.

What industry is XtalPi in?

XtalPi operates in Biotech, Artificial Intelligence.

How many employees does XtalPi have?

XtalPi has 1001-5000 employees.

XtalPi

IPO

Beijing, China · Founded 2015 · $785.1M raised

Biotech

Artificial Intelligence

Headquarters: Beijing
Employees: 1001–5000
Founded: 2015
Business Model: B2B

Website: en.xtalpi.com
Total Funding: $785.1M
Last Round: $400.0M Series DJan 2021
Rounds: 6

About

XtalPi is an AI-powered pharmaceutical technology company founded in 2015 by MIT physicists, combining quantum physics, artificial intelligence, and robotics to revolutionize drug discovery and materials science. The company's platform, which began with industry-leading crystal structure prediction (CSP) capabilities proven in collaboration with Pfizer, has expanded to cover the full drug R&D workflow including molecular simulation, antibody discovery, and intelligent lab automation. XtalPi employs over 1,000 people, holds 300+ granted patents, and partners with 80+ pharmaceutical and biotech companies globally. The company listed on the Hong Kong Stock Exchange in 2024.

Summary

XtalPi is a Biotech company based in Beijing, China, founded in 2015. It has raised $785.1M in total across 6 rounds, most recently a $400.0M Series D round in Jan 2021. Investors include Tencent, SoftBank and PICC Capital Investment.